- Home
- NERV vs NTRP Comparison
NERV vs NTRP Comparison
Compare NERV & NTRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- NTRP
- Stock Information
- Founded
- NERV 2007
- NTRP 1985
- Country
- NERV United States
- NTRP United States
- Employees
- NERV N/A
- NTRP N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- NTRP
- Sector
- NERV Health Care
- NTRP
- Exchange
- NERV Nasdaq
- NTRP NYSE
- Market Cap
- NERV 12.0M
- NTRP 12.7M
- IPO Year
- NERV 2014
- NTRP N/A
- Fundamental
- Price
- NERV $2.00
- NTRP $4.13
- Analyst Decision
- NERV Hold
- NTRP Hold
- Analyst Count
- NERV 1
- NTRP 1
- Target Price
- NERV $5.00
- NTRP $5.00
- AVG Volume (30 Days)
- NERV 17.0K
- NTRP 34.5K
- Earning Date
- NERV 08-05-2025
- NTRP 07-15-2025
- Dividend Yield
- NERV N/A
- NTRP N/A
- EPS Growth
- NERV N/A
- NTRP N/A
- EPS
- NERV 0.83
- NTRP N/A
- Revenue
- NERV N/A
- NTRP $451,457.00
- Revenue This Year
- NERV N/A
- NTRP $2,544.87
- Revenue Next Year
- NERV N/A
- NTRP N/A
- P/E Ratio
- NERV $2.40
- NTRP N/A
- Revenue Growth
- NERV N/A
- NTRP N/A
- 52 Week Low
- NERV $1.15
- NTRP $1.39
- 52 Week High
- NERV $3.35
- NTRP $8.50
- Technical
- Relative Strength Index (RSI)
- NERV 62.19
- NTRP 61.23
- Support Level
- NERV $1.94
- NTRP $3.62
- Resistance Level
- NERV $2.32
- NTRP $4.25
- Average True Range (ATR)
- NERV 0.14
- NTRP 0.38
- MACD
- NERV 0.03
- NTRP -0.01
- Stochastic Oscillator
- NERV 56.55
- NTRP 82.42
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About NTRP NEXTTRIP INC
NextTrip Inc is a technology-driven platform delivering travel booking and travel media solutions. It provides individual and group travelers with vacations to popular and sought-after destinations in Mexico, the Caribbean, and across the world. NextTrip Media platform - Travel Magazine offers a social media platform for viewers to explore, educate, and share with friends their bucket list travel. The company is also launching an end-to-end content ecosystem that uses AI-assisted travel planning capturing advertising, building brand awareness, rewarding loyalty, and driving bookings.